Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity
出版年份 2023 全文链接
标题
Selective Inhibition of PI3K Isoforms in Brain Tumors Suppresses Tumor Growth by Increasing Radiosensitivity
作者
关键词
-
出版物
YONSEI MEDICAL JOURNAL
Volume 64, Issue 2, Pages 139
出版商
Yonsei University College of Medicine
发表日期
2023-01-20
DOI
10.3349/ymj.2022.0414
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Combining radiation with PI3K isoform-selective inhibitor administration increases radiosensitivity and suppresses tumor growth in non-small cell lung cancer
- (2022) Mi Youn Seol et al. JOURNAL OF RADIATION RESEARCH
- PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy
- (2021) Fu-Cheng Chuang et al. PLoS One
- First-in-human Phase I study to evaluate the brain-penetrant PI3K/mTOR inhibitor GDC-0084 in patients with progressive or recurrent high-grade glioma
- (2020) Patrick Y. Wen et al. CLINICAL CANCER RESEARCH
- Radioresistance in Glioblastoma and the Development of Radiosensitizers
- (2020) Md Yousuf Ali et al. Cancers
- Behaviors of Glioblastoma Cells in in Vitro Microenvironments
- (2019) Wenwen Diao et al. Scientific Reports
- Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors
- (2019) Ying Zhang et al. Expert Opinion on Drug Metabolism & Toxicology
- Management of toxicity to isoform α-specific PI3K inhibitors
- (2019) S E Nunnery et al. ANNALS OF ONCOLOGY
- Clinically relevant radioresistant cell line: a simple model to understand cancer radioresistance
- (2017) Yoshikazu Kuwahara et al. Medical Molecular Morphology
- Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
- (2017) Hua-fu Zhao et al. Molecular Cancer
- Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
- (2017) Aviram Mizrachi et al. Nature Communications
- PI3K inhibitors as new cancer therapeutics: implications for clinical trial design
- (2016) Cristian Massacesi et al. OncoTargets and Therapy
- Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancer
- (2015) S. Chia et al. Current Oncology
- A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
- (2015) Manfred Westphal et al. EUROPEAN JOURNAL OF CANCER
- Molecules in medicine mini-review: isoforms of PI3K in biology and disease
- (2015) Bart Vanhaesebroeck et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The PI3K/AKT/mTOR interactive pathway
- (2015) Tulin Ersahin et al. Molecular BioSystems
- The Brain Microenvironment Preferentially Enhances the Radioresistance of CD133+ Glioblastoma Stem-like Cells
- (2015) Muhammad Jamal et al. NEOPLASIA
- DNA double-strand break repair pathway choice and cancer
- (2014) Tomas Aparicio et al. DNA REPAIR
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
- (2014) Olivier L. Chinot et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up
- (2013) Julien Vignard et al. RADIOTHERAPY AND ONCOLOGY
- mTORC1 Inhibition Is Required for Sensitivity to PI3K p110 Inhibitors in PIK3CA-Mutant Breast Cancer
- (2013) M. Elkabets et al. Science Translational Medicine
- Targeting the Akt-pathway to Improve Radiosensitivity in Glioblastoma
- (2012) Ravi S. Narayan et al. CURRENT PHARMACEUTICAL DESIGN
- PI3K: A potential therapeutic target for cancer
- (2011) Yingwei Chen et al. JOURNAL OF CELLULAR PHYSIOLOGY
- EGFRvIII and DNA Double-Strand Break Repair: A Molecular Mechanism for Radioresistance in Glioblastoma
- (2009) B. Mukherjee et al. CANCER RESEARCH
- Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells
- (2009) Hui-Fang Li et al. Radiation Oncology
- Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
- (2008) R. Prevo et al. CANCER RESEARCH
- Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach
- (2008) Cristóbal Belda-Iniesta et al. Clinical & Translational Oncology
- Targeting the PI3K p110 Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
- (2008) A. S. Guerreiro et al. CLINICAL CANCER RESEARCH
- Essential roles of PI(3)K–p110β in cell growth, metabolism and tumorigenesis
- (2008) Shidong Jia et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now